Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMS - Adamas Pharma's Gocovri meets endpoint in late-stage MS study
December, 17 2019 09:24 AM
Adamas Pharmaceuticals Inc.
Adamas Pharmaceuticals (NASDAQ:ADMS ) announces positive results from a Phase 3 clinical trial, INROADS , evaluating Gocovri (amantadine) (ADS-5102) in multiple sclerosis (MS) patients with walking impairment. More news on: Adamas Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Stock Information
Company Name:
Adamas Pharmaceuticals Inc.
Stock Symbol:
ADMS
Market:
NASDAQ
Website:
adamaspharma.com
Get ADMS Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .